The Trump administration is pushing to fast-track psychedelic drug approvals as his economic approval ratings hit record lows, marking a sharp reversal from his first term stance on drugs. Three companies, Compass Pathways, Transcend Therapeutics and Usona Institute received priority FDA review vouchers under the executive order. Scientists and veterans are divided on whether the move is driven by a genuine commitment to mental health or political calculation.
Chapters:
00:00 - 01:17 Introduction
01:18 - 03:49 Chapter 1: Legitimizing a new wave of drugs
03:50 - 06:20 Chapter 2: Lead with science
06:21 - 09:44 Chapter 3: Political pressure
Reporting by: Brandon Gomez
Produced and Shot by: Ryan Baker
Edited by: Darren Geeter
Animation: Jason Reginato, Alisa Stern
Senior Director of Video: Lindsey Jacobson
Additional Footage: Getty Images, Healing Breakthrough, Marie Phelan, Juliana Mercer
» Subscribe to CNBC:
» Subscribe to CNBC TV:
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Want to get ahead at work? Then you need to learn how to make effective small talk. In CNBC’s new online course, How To Talk To People At Work, expert instructors teach you how to use everyday conversation to gain visibility, build meaningful relationships and advance your career. Sign up now:
Connect with CNBC News Onlin
|
The economics of AI are getting harder t...
#yahoofinance #business #stockmarket US...
== AlphaSpace by Yahoo Finance: A Profes...
For the third month in a row, the jobs r...
== AlphaSpace by Yahoo Finance: A Profes...
Why bitcoin sitting on the 200 weekly mo...
Bloomberg’s Ed Ludlow breaks down Elon M...
Software has dominated venture capital f...
Philip Johnston, Starcloud CEO, joins to...
Supernatural, the VR fitness app for Met...
The May jobs report came in stronger tha...
After Apple's WWDC 2026 keynote, join Th...
While the AI fundraising machine keeps b...